| Target Price | $35.70 |
| Price | $27.42 |
| Potential | 30.20% |
| Number of Estimates | 20 |
| 20 Analysts have issued a price target Keurig Dr Pepper Inc 2026 . The average Keurig Dr Pepper Inc target price is $35.70. This is 30.20% higher than the current stock price. The highest price target is $44.10 60.83% , the lowest is $24.24 11.60% . | |
| A rating was issued by 23 analysts: 14 Analysts recommend Keurig Dr Pepper Inc to buy, 8 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Keurig Dr Pepper Inc stock has an average upside potential 2026 of 30.20% . Most analysts recommend the Keurig Dr Pepper Inc stock at Purchase. |
22 Analysts have issued a sales forecast Keurig Dr Pepper Inc 2025 . The average Keurig Dr Pepper Inc sales estimate is $16.6b . This is 2.63% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $17.3b 7.26% , the lowest is $15.7b 2.77% .
This results in the following potential growth metrics:
| 2024 | $15.4b | 3.62% |
|---|---|---|
| 2025 | $16.6b | 8.14% |
| 2026 | $17.4b | 4.69% |
| 2027 | $18.1b | 3.90% |
| 2028 | $18.5b | 2.35% |
| 2029 | $19.1b | 3.29% |
| 2030 | $19.7b | 3.30% |
17 Analysts have issued an Keurig Dr Pepper Inc EBITDA forecast 2025. The average Keurig Dr Pepper Inc EBITDA estimate is $4.9b . This is 33.48% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $5.2b 42.13% , the lowest is $4.4b 19.77% .
This results in the following potential growth metrics and future EBITDA Margins:
| 2024 | $3.7b | 6.25% |
|---|---|---|
| 2025 | $4.9b | 31.90% |
| 2026 | $5.2b | 6.38% |
| 2027 | $5.4b | 3.49% |
| 2028 | $5.5b | 2.68% |
| 2029 | $5.7b | 3.55% |
| 2030 | $6.0b | 3.57% |
| 2024 | 24.24% | 2.54% |
|---|---|---|
| 2025 | 29.57% | 21.99% |
| 2026 | 30.04% | 1.59% |
| 2027 | 29.92% | 0.40% |
| 2028 | 30.02% | 0.33% |
| 2029 | 30.10% | 0.27% |
| 2030 | 30.17% | 0.23% |
23 Keurig Dr Pepper Inc Analysts have issued a net profit forecast 2025. The average Keurig Dr Pepper Inc net profit estimate is $2.8b . This is 77.29% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $3.0b 86.65% , the lowest is $2.7b 70.84% .
This results in the following potential growth metrics and future Net Margins:
| 2024 | $1.4b | 33.93% |
|---|---|---|
| 2025 | $2.8b | 94.64% |
| 2026 | $3.0b | 5.96% |
| 2027 | $3.2b | 6.66% |
| 2024 | 9.39% | 36.24% |
|---|---|---|
| 2025 | 16.90% | 80.04% |
| 2026 | 17.10% | 1.18% |
| 2027 | 17.56% | 2.69% |
23 Analysts have issued a Keurig Dr Pepper Inc forecast for earnings per share. The average Keurig Dr Pepper Inc EPS is $2.06 . This is 77.59% higher than earnings per share in the financial year 2024. The highest EPS forecast is $2.17 87.07% , the lowest is $1.99 71.55% .
This results in the following potential growth metrics and future valuations:
| 2024 | $1.05 | 32.26% |
|---|---|---|
| 2025 | $2.06 | 96.19% |
| 2026 | $2.19 | 6.31% |
| 2027 | $2.33 | 6.39% |
| Current | 23.24 | 22.59% |
|---|---|---|
| 2025 | 13.06 | 43.81% |
| 2026 | 12.32 | 5.67% |
| 2027 | 11.55 | 6.25% |
Based on analysts' sales estimates for 2025, the Keurig Dr Pepper Inc stock is valued at an EV/Sales of 3.18 and an P/S ratio of 2.21 .
This results in the following potential growth metrics and future valuations:
| Current | 3.27 | 14.84% |
|---|---|---|
| 2025 | 3.18 | 2.71% |
| 2026 | 3.04 | 4.48% |
| 2027 | 2.92 | 3.75% |
| 2028 | 2.86 | 2.30% |
| 2029 | 2.77 | 3.18% |
| 2030 | 2.68 | 3.20% |
| Current | 2.26 | 20.12% |
|---|---|---|
| 2025 | 2.21 | 2.57% |
| 2026 | 2.11 | 4.48% |
| 2027 | 2.03 | 3.75% |
| 2028 | 1.98 | 2.30% |
| 2029 | 1.92 | 3.18% |
| 2030 | 1.86 | 3.19% |
Keurig Dr Pepper Inc...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Oct 28 2025 |
| Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | Oct 28 2025 |
| JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Oct 20 2025 |
| B of A Securities |
Buy
➜
Buy
|
Unchanged | Oct 08 2025 |
| Goldman Sachs |
Neutral
➜
Neutral
|
Unchanged | Oct 02 2025 |
| Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | Sep 25 2025 |
| Barclays |
Overweight
➜
Equal-Weight
|
Downgrade | Sep 24 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Oct 28 2025 |
|
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
Oct 28 2025 |
|
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Oct 20 2025 |
|
Unchanged
B of A Securities:
Buy
➜
Buy
|
Oct 08 2025 |
|
Unchanged
Goldman Sachs:
Neutral
➜
Neutral
|
Oct 02 2025 |
|
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
Sep 25 2025 |
|
Downgrade
Barclays:
Overweight
➜
Equal-Weight
|
Sep 24 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


